Read a new publication from Oncowitan: The drug Aliskiren to control blood pressure. Its use in the context of COVID-19.

Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study, Journal of Biomolecular Structure and Dynamics (2021)

Read here

Categories: News